Knowledge accumulation and industry evolution: the case of pharma-biotech

Contributor(s):

Publication details: New York Cambridge University Press 2006Description: xvii, 446 pISBN:

9780521858229

Subject(s):

DDC classification:

615.19

Summary: This volume examines how the biotechnology and pharmaceutical sector is affected by the dynamics of innovation, institutions, and public policy. It contributes both theoretically and empirically to the increasingly influential Schumpetarian framework in industrial economics, which places innovation at the centre of the analysis of competition. Both quantitative and qualitative studies are included, and this varied perspective adds to the richness of the volume's insights. The contributors explore different ideas regarding the historical evolution of technology in the sector, and how firms and industry structure have co-evolved with innovation dynamics. Important policy questions are considered regarding the future of innovation in this sector and its impact on the economy.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Call number	Status	Date due	Barcode	Item holds
Book	Ahmedabad	615.19 K6 (Browse shelf(Opens below))	Available		161279

Total holds: 0

Browsing Ahmedabad shelves Close shelf browser (Hides shelf browser)

Previous
Previous	615.19 H2Q8 Quality control training manual: comprehensive training guide for API, finished pharmaceutical and biotechnologies laboratories	615.19 B5B2 Basic principles of drug discovery and development	615.19 C4M6 Monte Carlo simulation for the pharmaceutical industry: concepts, algorithms, and case studies	615.19 K6 Knowledge accumulation and industry evolution: the case of pharma-biotech	615.1901 M8 Multiple testing problems in pharmaceutical statistics	615.1901 S8 Statistical methodology in the pharmaceutical sciences	615.1901072 B4 Biopharmaceutical sequential statistical applications

Includes bibliographical references and index

This volume examines how the biotechnology and pharmaceutical sector is affected by the dynamics of innovation, institutions, and public policy. It contributes both theoretically and empirically to the increasingly influential Schumpetarian framework in industrial economics, which places innovation at the centre of the analysis of competition. Both quantitative and qualitative studies are included, and this varied perspective adds to the richness of the volume's insights. The contributors explore different ideas regarding the historical evolution of technology in the sector, and how firms and industry structure have co-evolved with innovation dynamics. Important policy questions are considered regarding the future of innovation in this sector and its impact on the economy.

There are no comments on this title.

to post a comment.